The family shareholder group that holds a 45.01% stake in Roche on Thursday added seven members from the next generation to the group, saying the move underscored the family's desire to preserve the pharmaceutical company's independence long-term. The Roache DNA Project which includes all variant spellings, is for people who are interested in exploring their family history. By using our website you agree to our use of cookies in accordance with our cookie policy.

We don’t have to worry about externalities.’ But this is clearly, to my understanding, not true,” says Hoffmann.“We need to look at financial returns, because without that, there's nothing.

Business is often too focused on short-term gains, Hoffmann says, and is rarely interested in its impact on society and the environment. Global Family Business and EMEA Entrepreneurial and Private Business Leader, Partner, PwC Germany

The rankings of business schools are often based on the salary you earn when you graduate. The shares are bearer shares and the Group does not maintain a register of shareholders. On 20 October 2005 Hoffmann-La Roche decided to license other companies to manufacture Oseltamivir.Also in 2005 Roche acquired the Swiss company GlycArt Biotechnology in order to acquire technology to On 12 March 2009 Roche agreed to fully acquire Genentech, which it had held a majority stake since 1990,Roche acquired Medingo Ltd. in April 2010 for $160 millionIn 2011, the company received the International Society for Pharmaceutical Engineering Facility of the Year Award for Process Innovation for Roche’s "MyDose" Clinical Supply project.On 26 June 2012, Roche announced the closure of the Nutley/Clifton campus, which was completed in 2013.

Your request has been routed to the appropriate person.

By using our website you agree to our use of cookies in accordance with our cookie policy. And this sustainability is lived by the family.”To illustrate this, one need look no further than Hoffmann’s early life.

We need to be able to provide the right environment and have sufficient stability while still maintaining a certain amount of excitement.”For Hoffmann, all of this lays the foundations for Roche’s legacy.

The property is in the process of remediation.In July 2013, Roche Diagnostics acquired blood diagnostics company Constitution Medical Inc. for $220 million.On 7 April 2014, Roche announced its intention to acquire IQuum for up to $450 million,On 16 January 2015, the company announced that they would acquire In August, the company announced its intention to acquire GeneWEAVE , Inc. for up to $425 million in order to strengthen its microbial diagnostics business.In January 2016, the company announced it would acquire Tensha Therapeutics for $115 million upfront, with $420 million in contingent payments.In January 2017, the company acquired ForSight VISION4.In February 2018, Roche announced it would acquire Flatiron Health, a business specialising in US cancer data analytics, for $1.9 billion.In February 2019, the business announced it would acquire Hoffmann-La Roche is strong in the field pharmaceuticals for cancer treatment, against virus diseases and for treatment of metabolic diseases.

In 1995 Syntex becomes Roche Bioscience, one of the Group’s major research and development sites. Roche strengthens its position in international and US pharmaceutical markets in 1994 by acquiring Palo Alto-based Syntex Corporation.

For the most part, and contrary to popular opinion, these spelling variations are of little significance.

"That’s what separates us from non family-owned businesses.

Showing 1-20 of 68 topics. The donor was André Hoffmann, Vice Chairman of pharmaceuticals group Roche and a member of the family with a controlling shareholding in the group since 1948.Yet the money – actually gifted in his name and that of his wife, Rosalie – was not just an eye-catching case of corporate and personal largesse.